Publication

Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins: 2-Year Results

Disselhoff, B. C. V. M., Buskens, E., Kelder, J. C., Kinderen, D. J. D. & Moll, F. L., Mar-2009, In : European Journal of Vascular and Endovascular Surgery. 37, 3, p. 357-363 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

APA

Disselhoff, B. C. V. M., Buskens, E., Kelder, J. C., Kinderen, D. J. D., & Moll, F. L. (2009). Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins: 2-Year Results. European Journal of Vascular and Endovascular Surgery, 37(3), 357-363. https://doi.org/10.1016/j.ejvs.2008.11.013

Author

Disselhoff, B. C. V. M. ; Buskens, E. ; Kelder, J. C. ; Kinderen, D. J. der ; Moll, F. L. / Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins : 2-Year Results. In: European Journal of Vascular and Endovascular Surgery. 2009 ; Vol. 37, No. 3. pp. 357-363.

Harvard

Disselhoff, BCVM, Buskens, E, Kelder, JC, Kinderen, DJD & Moll, FL 2009, 'Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins: 2-Year Results', European Journal of Vascular and Endovascular Surgery, vol. 37, no. 3, pp. 357-363. https://doi.org/10.1016/j.ejvs.2008.11.013

Standard

Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins : 2-Year Results. / Disselhoff, B. C. V. M.; Buskens, E.; Kelder, J. C.; Kinderen, D. J. der; Moll, F. L.

In: European Journal of Vascular and Endovascular Surgery, Vol. 37, No. 3, 03.2009, p. 357-363.

Research output: Contribution to journalArticleAcademicpeer-review

Vancouver

Disselhoff BCVM, Buskens E, Kelder JC, Kinderen DJD, Moll FL. Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins: 2-Year Results. European Journal of Vascular and Endovascular Surgery. 2009 Mar;37(3):357-363. https://doi.org/10.1016/j.ejvs.2008.11.013


BibTeX

@article{c2e28bef8a5e4c82b72187e2ab019b1d,
title = "Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins: 2-Year Results",
abstract = "Background: Although endovenous laser ablation for varicose veins is replacing surgical stripping, proper economic evaluation with adequate follow-up in a randomised clinical trial is important for considered policy decisions regarding the implementation of new techniques.Methods: Data from a randomised controlled trial comparing cryostripping and endovenous laser ablation in 120 patients were combined to study Short Form (SF) 6D outcome, costs and cost-effectiveness 2 years after treatment. Incremental cost per quality-adjusted life year (QALY) gained 2 years after treatment was calculated using different strategies, and uncertainty was assessed with bootstrapping.Results: Over the total study period, mean SF-6D scores improved slightly from 0.78 at baseline to 0.80 at 2 years for patients who underwent cryostripping and from 0.77 to 0.79 for patients who underwent endovenous laser. QALY (SF-6D) was 1.59 in patients who underwent cryostripping and 1.60 in patients who underwent endovenous laser 2 years after treatment. The costs of cryostripping and endovenous laser per patient were (sic)2651 and (sic)2783, respectively. Bootstrapping indicated that cryostripping was associated with an incremental cost-effectiveness ratio of (sic)32 per QALY gained. With regard to different strategies, outpatient cryostripping was less costly and more effective 2 years after treatment.Conclusion: In this study, in terms of costs per QALY gained, outpatient cryostripping appeared to be the dominant strategy, but endovenous laser yielded comparable outcomes for a relatively little additional cost. (C) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.",
keywords = "Endovenous laser, Cryostripping, Costs and cost-effectiveness, SAPHENOUS-VEIN, TRIAL, DISEASE, LONG",
author = "Disselhoff, {B. C. V. M.} and E. Buskens and Kelder, {J. C.} and Kinderen, {D. J. der} and Moll, {F. L.}",
year = "2009",
month = "3",
doi = "10.1016/j.ejvs.2008.11.013",
language = "English",
volume = "37",
pages = "357--363",
journal = "European Journal of Vascular and Endovascular Surgery",
issn = "1078-5884",
publisher = "W B SAUNDERS CO LTD",
number = "3",

}

RIS

TY - JOUR

T1 - Randomised Comparison of Costs and Cost-Effectiveness of Cryostripping and Endovenous Laser Ablation for Varicose Veins

T2 - 2-Year Results

AU - Disselhoff, B. C. V. M.

AU - Buskens, E.

AU - Kelder, J. C.

AU - Kinderen, D. J. der

AU - Moll, F. L.

PY - 2009/3

Y1 - 2009/3

N2 - Background: Although endovenous laser ablation for varicose veins is replacing surgical stripping, proper economic evaluation with adequate follow-up in a randomised clinical trial is important for considered policy decisions regarding the implementation of new techniques.Methods: Data from a randomised controlled trial comparing cryostripping and endovenous laser ablation in 120 patients were combined to study Short Form (SF) 6D outcome, costs and cost-effectiveness 2 years after treatment. Incremental cost per quality-adjusted life year (QALY) gained 2 years after treatment was calculated using different strategies, and uncertainty was assessed with bootstrapping.Results: Over the total study period, mean SF-6D scores improved slightly from 0.78 at baseline to 0.80 at 2 years for patients who underwent cryostripping and from 0.77 to 0.79 for patients who underwent endovenous laser. QALY (SF-6D) was 1.59 in patients who underwent cryostripping and 1.60 in patients who underwent endovenous laser 2 years after treatment. The costs of cryostripping and endovenous laser per patient were (sic)2651 and (sic)2783, respectively. Bootstrapping indicated that cryostripping was associated with an incremental cost-effectiveness ratio of (sic)32 per QALY gained. With regard to different strategies, outpatient cryostripping was less costly and more effective 2 years after treatment.Conclusion: In this study, in terms of costs per QALY gained, outpatient cryostripping appeared to be the dominant strategy, but endovenous laser yielded comparable outcomes for a relatively little additional cost. (C) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

AB - Background: Although endovenous laser ablation for varicose veins is replacing surgical stripping, proper economic evaluation with adequate follow-up in a randomised clinical trial is important for considered policy decisions regarding the implementation of new techniques.Methods: Data from a randomised controlled trial comparing cryostripping and endovenous laser ablation in 120 patients were combined to study Short Form (SF) 6D outcome, costs and cost-effectiveness 2 years after treatment. Incremental cost per quality-adjusted life year (QALY) gained 2 years after treatment was calculated using different strategies, and uncertainty was assessed with bootstrapping.Results: Over the total study period, mean SF-6D scores improved slightly from 0.78 at baseline to 0.80 at 2 years for patients who underwent cryostripping and from 0.77 to 0.79 for patients who underwent endovenous laser. QALY (SF-6D) was 1.59 in patients who underwent cryostripping and 1.60 in patients who underwent endovenous laser 2 years after treatment. The costs of cryostripping and endovenous laser per patient were (sic)2651 and (sic)2783, respectively. Bootstrapping indicated that cryostripping was associated with an incremental cost-effectiveness ratio of (sic)32 per QALY gained. With regard to different strategies, outpatient cryostripping was less costly and more effective 2 years after treatment.Conclusion: In this study, in terms of costs per QALY gained, outpatient cryostripping appeared to be the dominant strategy, but endovenous laser yielded comparable outcomes for a relatively little additional cost. (C) 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.

KW - Endovenous laser

KW - Cryostripping

KW - Costs and cost-effectiveness

KW - SAPHENOUS-VEIN

KW - TRIAL

KW - DISEASE

KW - LONG

U2 - 10.1016/j.ejvs.2008.11.013

DO - 10.1016/j.ejvs.2008.11.013

M3 - Article

VL - 37

SP - 357

EP - 363

JO - European Journal of Vascular and Endovascular Surgery

JF - European Journal of Vascular and Endovascular Surgery

SN - 1078-5884

IS - 3

ER -

ID: 4879361